CEO Viewpoint: Dr Daniel Tan on future-proofing your lab (and career)

BulletArticle
Q&A with Dr Daniel Tan, CEO of Parkway Laboratories

As CEO of Parkway Laboratory Services (PLS) and Angsana Molecular & Diagnostic Laboratory (AMDL) in Singapore, Dr Daniel Tan has extensive experience in clinical lab management and transformation. In this interview with Lab Insights, he answers questions on a variety of topics, including:

  • [00:07] – current role at PLS and AMDL
  • [01:06] – career journey and learnings along the way
  • [02:30] – approach to quality management and accreditation
  • [03:13] – overall digital strategy
  • [05:08] – use of digital apps to improve patient engagement
  • [05:38] – use of digital apps for lab-clinician collaboration
  • [06:24] – experience with digital health passport technologies
  • [08:07] – precision medicine offerings and plans
  • [08:53] – views on NGS adoption and its benefits
  • [11:13] – strategies for accelerating NGS adoption
  • [12:10] – advice for lab professionals to future-proof their careers in times of rapid change

 

 

Watch the full Q&A below (click the buttons on the play bar to jump to any specific segment that interests you).

同じトピックの記事

おすすめのトピック

配列決定RED 2020Rare Diseases
次のおすすめ記事
Scroll to Top